![]() |
市場調查報告書
商品編碼
1722809
空心膠囊市場規模、佔有率、趨勢及預測(按類型、原料、功能、治療應用、最終用戶和地區),2025 年至 2033 年Empty Capsules Market Size, Share, Trends and Forecast by Type, Raw Material, Functionality, Therapeutic Application, End User, and Region, 2025-2033 |
2024 年全球空心膠囊市場規模價值 32.6 億美元。展望未來, IMARC Group估計到 2033 年市場規模將達到 56.7 億美元,2025 年至 2033 年的複合年成長率為 6.28%。北美目前佔據市場主導地位,2024 年的市佔率將超過 34.5%。膠囊中膠囊技術的興起,確保了患者的胃腸道安全,再加上醫療保健行業的許多進步,主要推動了該地區市場的發展。
主要市場促進因素:慢性病盛行率的上升是推動全球市場發展的主要動力。此外,非明膠膠囊(如羥丙基甲基纖維素(HPMC))由於其透明度、適中的強度、耐油脂特性等而日益普及,也是另一個重要的成長誘導因素。
主要市場趨勢:醫療保健領域的主要參與者對引進創新療法和藥物的廣泛投資是推動市場發展的新興趨勢之一。此外,速釋膠囊的發展也對市場成長產生了正面影響。
競爭格局:全球市場上一些知名的公司包括 ACG Associated Capsules Pvt。 Ltd.、Bright Pharma Caps Inc.、CapsCanada Corporation、HealthCaps India Limited、Lonza Group AG、Medicaps Limited、Qualicaps Co. Ltd.(三菱化學控股公司)、Nectar Lifesciences Limited、Roxlor LLC、山西廣生藥用膠囊有限公司、Snail Pharma Industry Co. Ltd、Suheung Co. Ltd 等。
地理趨勢:由於注重健康的人群對膳食補充劑的趨勢日益增強,北美在市場上佔據明顯主導地位。除此之外,空膠囊供應商和明膠製造商之間的各種策略合作也促進了區域市場的成長。
挑戰與機會:空心膠囊市場面臨的主要挑戰之一是確保膠囊的穩定性以及與多種活性藥物成分(API)的兼容性。然而,材料科學的不斷進步,開發出創新的膠囊材料和配方,增強穩定性並減少與各種 API 的相互作用,預計將在未來幾年推動市場發展。
慢性病的發生
老年人口的不斷成長使得易患慢性疾病的人群對以膠囊形式生產具有治療效果的藥物的需求不斷增加,因為與其他口服劑型相比,膠囊易於吞嚥並且溶解時間更快。根據世界衛生組織 (WHO) 的數據,預計 2020 年至 2050 年間,80 歲或以上人口的數量將增加兩倍,達到約 4.26 億。此外,根據美國人口參考局《人口公報-老化》顯示,到2060年,美國65歲及以上人口預計將從2018年的5,200萬人增加近一倍至9,500萬人。此外,心血管疾病(CVD)在全球範圍內非常普遍。根據世界衛生組織2019年發布的資料,估計每年有1,790萬人因心血管疾病發生率上升而死亡,預計到2030年這一數字將成長到2,360多萬人。此外,根據英國心臟基金會中心的數據,2021年英國約有760萬人患有心臟和循環系統疾病。因此,這些病例的發生率不斷上升,促進了心血管治療藥物的有效治療,為空心膠囊市場前景提供了積極的推動力。
新產品發布
製藥業先進封裝解決方案的引入正在推動市場的發展。主要參與者正在開發增強型空膠囊變體,例如 HPMC 膠囊,作為硬明膠膠囊的素食替代品,並滿足某些飲食和文化需求。例如,Capsugel 是一家著名的空膠囊製造商,擁有 20 多年的硬明膠膠囊製造經驗及其他技術,提供一系列用於吸入和口服藥物應用的羥丙基甲基纖維素 (HPMC) 膠囊。另一個例子是 ACG 於 2022 年 3 月開發的 ACGcaps NTone,它提供源自可食用來源的天然色素選擇,吸引注重健康的人士。此外,作為合約 HPMC 和硬明膠膠囊製造服務的主要參與者之一,Suheung Capsule 為製藥業提供高度穩定的硬明膠膠囊殼材料。除此之外,歐洲藥品管理局(EMA)和美國食品藥物管理局(FDA)越來越多的監管批准正在簡化新配方的流程,這反過來又是空膠囊市場近期的機會之一。例如,2020年4月,硬膠囊和製藥相關設備製造商之一Qualicaps與該地區多家領先公司簽署了代理和分銷合作協議,擴大了其在中東和非洲的業務。同樣,2020年8月,雷迪博士實驗室獲得美國FDA批准,開發可用於治療胱胺酸尿症和威爾遜氏症的學名藥青黴胺膠囊。
採用膳食補充劑
膠囊形式的藥妝品和營養保健品(例如 CosmoPod 膠囊和鱈魚肝油膠囊)的日益流行,成為重要的成長誘導因素。根據 IMARC 發布的報告,2023 年全球營養保健品市場規模達 4,685 億美元。展望未來, IMARC Group預計到 2032 年市場規模將達到 8,563 億美元,2024-2032 年期間的成長率 (CAGR) 為 6.7%。因此,以膠囊形式推出的補充劑為新配方提供了有利可圖的機會,從而推動了空膠囊市場的需求。例如,2023 年 12 月,總部位於孟買的膠囊製造供應商之一 ACG 開發了一種新穎的營養保健品設計,採用並排技術將膠囊分成兩個隔間,從而可以將液體和粉末等兩種不同形式的成分製成一個膠囊。除此之外,膳食補充劑標籤資料庫 (DSLD) 的資料顯示,大約有 50,000 種膳食補充劑膠囊、軟膠囊、片劑、粉末、液體、軟糖和小包裝產品可供選擇。這些產品大多為單一維生素、複合維生素、胺基酸、草藥、複合礦物質等多種劑型。此外,DSLD資料顯示,有超過 17,000 種產品以膠囊形式提供,屬於多個類別,佔所有劑型的 34%。這反過來又推動了全球市場的發展。
目前,明膠膠囊佔據最大的市場佔有率
明膠膠囊,也稱為凝膠帽,是營養保健品和製藥行業常用的一種口服劑型,因為它使用方便、用途廣泛,並且能夠掩蓋封裝物質的不良味道和氣味。此外,它們通常有硬質和軟質兩種形式。硬明膠膠囊廣泛用於乾燥、粉狀成分和顆粒,而軟明膠膠囊則非常適合油和液體配方。具有最佳特性(例如提高的穩定性和改進的釋放特性)的明膠膠囊的推出正在促進該領域的成長。例如,Suheung 等公司提供為最佳化穩定性而製造的 EMBO CAPS 膠囊。這些膠囊也採用高級原料生產,包括來自 Suheung 子公司 Geltech 的明膠。此外,嚴格的規格合規性和電腦化的原料交叉混合確保只有符合精確要求的粉末才能到達膠囊機。除此之外,2023年2月,Vivion公司推出了多種空心明膠膠囊。
其中,豬肉在空心膠囊市場佔有率中佔據明顯主導地位
豬肉,特別是豬肉明膠,由於其廣泛的可用性和優異的膠凝性能,在市場佔有率中佔據明顯主導地位,這對於膠囊製造至關重要。豬明膠因其穩定的品質和能夠形成在胃中迅速溶解的堅固而柔韌的膠囊的能力而受到青睞。例如,Capsugel 在其廣泛使用的膠囊中採用豬肉明膠,從而確保可靠的性能。此外,2021 年 11 月,國際明膠製造商協會報告稱,包括膠囊在內的藥物應用中使用的明膠約 85% 來自豬肉。這種主導地位也得益於完善的供應鏈以及與牛明膠或魚明膠等其他來源相比豬明膠較低的生產成本。儘管由於飲食限制和道德問題,人們對替代來源的興趣日益濃厚,但豬明膠仍然是業界的首選。
目前,速釋膠囊佔據全球大部分市場佔有率
對需要快速起效的藥物傳輸需求的不斷成長促進了這一領域的成長。速釋膠囊在胃中快速溶解,迅速釋放內容物,快速發揮治療效果,使其成為各種藥品和營養保健產品的理想選擇。例如,2022 年 8 月,ACG 推出了其速釋膠囊系列 ACGcaps IR,該系列專門設計用於最佳化活性成分的釋放特性,從而提高其功效和患者依從性。同樣,2023 年 1 月,Capsugel 推出了具有速釋特性的 Vcaps Plus 膠囊,專為高速填充製程而設計,可確保快速溶解和生物利用度。這些創新滿足了對有效和快速起效藥物日益成長的需求,從而提高了空膠囊市場的近期價格。
阿莫西林等抗生素膠囊的使用日益增多,由於其易於吞嚥和劑型可控,有助於提高患者的依從性。此外,由於消費者對健康和保健的關注度日益提高,維生素和膳食補充劑也佔據了很大的市場佔有率。膠囊提供了一種方便的方式來獲取必需營養素,例如通常以膠囊形式存在的 Omega-3 脂肪酸和維生素 D。制酸劑和抗脹氣劑可受益於膠囊快速緩解消化問題的能力。在心血管治療中,它們確保準確地輸送他汀類藥物和抗高血壓藥物,這些藥物對於治療慢性心臟病至關重要。除此之外,其他治療領域,包括疼痛管理和荷爾蒙療法,也利用膠囊的多功能性和藥物傳遞的有效性,預計這將在未來幾年增加空膠囊市場的收入。
目前,製藥業佔據全球大部分市場佔有率
根據空膠囊市場統計數據,對患者友善遞送方式的需求不斷增加,正在刺激市場的發展。空膠囊為封裝各種類型的藥物(從粉末和顆粒到液體和半固體)提供了可靠的形式。例如,2023 年 9 月,龍沙報告稱,其 Capsugel 硬明膠膠囊的需求大幅增加,這得益於其在新型藥物配方和臨床試驗中的應用。這些膠囊因其穩定的性能和與多種活性藥物成分 (API) 的兼容性而受到青睞。同樣,Qualicaps 開發了新系列的 Quali-G 硬明膠膠囊,專為需要精確劑量和增強穩定性的高效藥物而設計。製藥業的主要參與者也利用空膠囊進行控釋製劑,以提高治療效果和患者遵從性。
根據空心膠囊市場概況,北美目前佔據全球市場佔有率的主導地位
市場研究報告也對所有主要區域市場進行了全面分析,包括北美(美國和加拿大);亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等);以及中東和非洲。報告顯示,北美佔據最大的市場佔有率。
慢性病發病率的上升以及美國老年人口的擴大正在刺激區域市場的發展。根據美國人口參考局的《人口公報—老化》顯示,到 2060 年,美國 65 歲及以上人口數量預計將從 2018 年的 5,200 萬人增加近一倍至 9,500 萬人。除此之外,對膠囊型營養保健品配方的需求不斷成長也是另一個重要的成長誘導因素。根據CRN消費者調查,77%的美國人表示在2019年食用了膳食補充劑。此外,調查也顯示,維生素和礦物質是同年美國民眾最常食用的補充劑,佔膳食補充劑總消費量的76%。除此之外,加拿大結構良好的醫療保健系統也鼓勵對研發活動的投資,預計這將在預測期內推動北美空心膠囊市場的發展。
市場研究報告對競爭格局進行了全面的分析。也提供了所有主要空心膠囊市場公司的詳細資料。市場中的一些主要參與者包括:
The global empty capsules market size was valued at USD 3.26 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 5.67 Billion by 2033, exhibiting a CAGR of 6.28% from 2025-2033. North America currently dominates the market, holding a market share of over 34.5% in 2024. The emerging popularity of capsule-in-capsule technology to ensure the gastrointestinal safety of patients, coupled with numerous advancements in the healthcare industry is primarily fueling the market in this region.
Major Market Drivers: The increasing prevalence of chronic diseases is primarily driving the global market. Moreover, the rising adoption of non-gelatin capsules, such as hydroxypropyl methylcellulose (HPMC), due to its transparency, moderate strength, resistance to oil and fat properties, etc., is also acting as another significant growth-inducing factor.
Key Market Trends: The widespread investments by key players in the healthcare sector for introducing innovative therapeutics and pharmaceutical drugs are among the emerging trends bolstering the market. Furthermore, the development of immediate-release capsules is also positively influencing the market growth.
Competitive Landscape: Some of the prominent companies in the global market include ACG Associated Capsules Pvt. Ltd., Bright Pharma Caps Inc., CapsCanada Corporation, HealthCaps India Limited, Lonza Group AG, Medicaps Limited, Qualicaps Co. Ltd. (Mitsubishi Chemical Holdings Corporation), Nectar Lifesciences Limited, Roxlor LLC, Shanxi Guangsheng Medicinal Capsules Co. Ltd, Snail Pharma Industry Co. Ltd, Suheung Co. Ltd, and Sunil Healthcare Limited, among many others.
Geographical Trends: North America exhibits a clear dominance in the market, owing to the increasing inclination among health-conscious individuals towards dietary supplements. Besides this, various strategic collaborations between empty capsule suppliers and gelatin manufacturers are contributing to the growth of the regional market.
Challenges and Opportunities: One of the major challenges in the empty capsules market is ensuring the stability and compatibility of capsules with a wide range of active pharmaceutical ingredients (APIs). However, continuous improvements in material science to develop innovative capsule materials and formulations that enhance stability and reduce interactions with diverse APIs are expected to fuel the market in the coming years.
Occurrence of Chronic Diseases
The expanding geriatric population who are susceptible to developing associated chronic conditions is escalating the demand for the production of therapeutically effective medicines in the form of capsules, as they are easy to swallow and have faster dissolution times compared to other oral dosage forms. According to the World Health Organization (WHO), the number of individuals aged 80 years or older is anticipated to triple between 2020 and 2050, reaching roughly about 426 million. Besides this, as stated by the Population Reference Bureau's Population Bulletin-Aging in the United States, the Americans aged 65 years and older are expected to nearly double from 52 million in 2018 to 95 million by 2060. Additionally, cardiovascular diseases (CVDs) are highly prevalent globally. As per the data published by the World Health Organization in 2019, an estimated 17.9 million people die each year due to the elevating incidences of cardiovascular diseases, and the number is projected to grow approximately to more than 23.6 million by 2030. Moreover, according to the British Heart Foundation Centre, around 7.6 million individuals were living with heart and circulatory diseases in 2021 across the United Kingdom. As a result, the rising incidences of these cases are bolstering the adoption of cardiovascular therapy drugs for effective treatment, which is providing a positive empty capsules market outlook.
Novel Product Launches
The introduction of advanced encapsulation solutions in the pharmaceutical industry is fueling the market. Key players are developing enhanced empty capsule variants, such as HPMC capsules, that serve as vegetarian alternatives to hard gelatin capsules and satisfy certain dietary and cultural needs. For example, Capsugel, one of the prominent empty capsules manufacturers with more than 20 years of experience in hard gelatin capsule manufacturing, amongst other technologies, provides a range of hydroxy propyl methyl cellulose (HPMC) capsules for inhalation and oral pharmaceutical applications. Another instance is the development of ACGcaps NTone by ACG in March 2022, which offers natural color options derived from edible sources, appealing to health-conscious individuals. Moreover, Suheung Capsule, one of the key players in contract HPMC and hard gelatin capsule manufacturing services, offers highly stable hard gelatin capsule shell materials for the pharmaceutical industry. Apart from this, the increasing number of regulatory approvals from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) are simplifying the process of new formulations, which, in turn, is one of the empty capsules market recent opportunities. For example, in April 2020, Qualicaps, one of the manufacturers of hard capsules and pharmaceutical-related equipment, expanded its presence in the Middle East and Africa after signing agency and distribution partnership agreements with a number of leading companies operating in the region. Similarly, in August 2020, Dr. Reddy Laboratories received USFDA approval for the development of generic Penicillamine capsules that can be used for the treatment of cystinuria and Wilson's disease.
Adoption of Dietary Supplements
The inflating popularity of cosmeceuticals and nutraceuticals that are preferred in capsule forms, such as CosmoPod capsules and cod liver oil capsules, respectively, is acting as a significant growth-inducing factor. According to the report published by IMARC, the global nutraceuticals market size reached US$ 468.5 Billion in 2023. Looking forward, IMARC Group anticipated the market to reach US$ 856.3 Billion by 2032, exhibiting a growth rate (CAGR) of 6.7% during 2024-2032. Consequently, the introduction of supplements in the form of capsules that allow lucrative opportunities for new formulations is propelling the empty capsules market demand. For instance, in December 2023, ACG, one of the Mumbai-based capsule manufacturing providers, developed a novel design for nutraceuticals by using side by sides technology that separates capsules into two compartments, thereby enabling ingredients of two different forms, such as liquid and powder, to be made into one capsule. Apart from this, the data from the Dietary Supplements Label Database (DSLD) revealed that roughly 50,000 dietary supplement capsules, softgel, tablet, powder, liquid, gummy, and packet products are available. Most of these products are numerous dosage forms of single vitamins, multi-vitamins, amino acids, herbals, multi-minerals, etc. Moreover, the DSLD data stated that more than 17,000 products are available as capsules under several categories, accounting for a 34 % share among all dosage forms. This, in turn, is driving the global market.
Currently, gelatin capsule accounts for the largest market share
Gelatin capsules, also called gel caps, represent a popular form of oral dosage used in the nutraceutical and pharmaceutical industries due to their ease of use, versatility, and ability to mask unpleasant tastes and odors of enclosed substances. Moreover, they are commonly available in both hard and soft forms. Hard gelatin capsules are widely used for dry, powdered ingredients and pellets, while soft gelatin capsules are ideal for oils and liquid-based formulations. The introduction of gelatin capsules with optimal properties, such as improved stability and modified release profiles, is augmenting the segment's growth. For instance, companies, such as Suheung, offer EMBO CAPS capsules that are manufactured to optimize stability. These capsules are also produced by adopting high-grade raw materials, including gelatine, which is sourced from Geltech, a subsidiary of Suheung. In addition, stringent specification compliance and computerized raw material cross-blending ensure only powders that meet the exact requirements can reach the capsulation machines. Apart from this, in February 2023, Vivion, Inc. introduced a wide range of empty gelatin capsules.
Among these, pig meat exhibits a clear dominance in the empty capsules market share
Pig meat, specifically pork-derived gelatin, exhibits a clear dominance in the market share, owing to its widespread availability and excellent gelling properties, which are crucial for capsule manufacturing. Pork gelatin is favored for its consistent quality and ability to form strong and flexible capsules that dissolve readily in the stomach. For example, Capsugel adopts pork-derived gelatin in their widely used capsules, thereby ensuring reliable performance. Additionally, in November 2021, the International Gelatin Manufacturers Association reported that approximately 85% of the gelatin used in pharmaceutical applications, including capsules, is derived from pork. This dominance is also driven by the well-established supply chains and lower production costs associated with pork gelatin compared to other sources, such as bovine or fish gelatin. Despite the growing interest in alternative sources due to dietary restrictions and ethical concerns, pork gelatin remains the preferred choice in the industry.
Currently, immediate-release capsules account for the majority of the global market share
The inflating need for delivering medications that require rapid onset of action is augmenting the growth in this segment. Immediate-release capsules dissolve quickly in the stomach, releasing their contents promptly for fast therapeutic effects, which makes them ideal for a broad range of pharmaceutical and nutraceutical products. For example, in August 2022, ACG launched its line of immediate-release capsules, ACGcaps IR, which are specifically designed to optimize the release profile of active ingredients, enhancing their efficacy and patient compliance. Similarly, in January 2023, Capsugel introduced their Vcaps Plus capsules with immediate-release properties, tailored for high-speed filling processes and ensuring quick dissolution and bioavailability. These innovations cater to the escalating demand for effective and fast-acting medications, which is elevating the empty capsules market's recent price.
The rising usage of capsules in antibiotics like amoxicillin helps to improve patient adherence due to their ease of swallowing and controlled dosage forms. Additionally, vitamins and dietary supplements also comprise a large portion of the market, driven by the growing consumer focus on health and wellness. Capsules offer a convenient way to consume essential nutrients, such as omega-3 fatty acids and vitamin D, which are often found in capsule form. Antacid and antiflatulent preparations benefit from the ability of capsules to deliver fast-acting relief from digestive issues. In cardiovascular therapy, they ensure the accurate delivery of drugs like statins and antihypertensives, which are crucial for managing chronic heart conditions. Besides this, other therapeutic areas, including pain management and hormonal therapies, utilize capsules for their versatility and efficacy in drug delivery, which is expected to bolster the empty capsules market revenue in the coming years.
Currently, the pharmaceutical industry account for the majority of the global market share
As per the empty capsules market statistics, the escalating demand for patient-friendly delivery methods is stimulating the market. Empty capsules provide a reliable form for encapsulating various types of medications, from powders and granules to liquids and semisolids. For instance, in September 2023, Lonza reported a significant increase in demand for its Capsugel hard gelatin capsules, driven by their use in novel drug formulations and clinical trials. These capsules are favored for their consistent performance and compatibility with a wide range of active pharmaceutical ingredients (APIs). Similarly, Qualicaps developed its new line of Quali-G hard gelatin capsules, which is designed specifically for high-potency drugs, which require precise dosing and enhanced stability. Key players in the pharmaceutical industry also leverage empty capsules for controlled-release formulations, enhancing therapeutic efficacy and patient compliance.
According to the empty capsules market overview, North America currently dominates the global market share
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
The increasing incidences of chronic diseases, along with the expanding geriatric population in the United States, are stimulating the regional market. According to the Population Reference Bureau's Population Bulletin-Aging in the United States, the number of individuals aged 65 years and older is expected to nearly double from 52 million in 2018 to 95 million by 2060. Besides this, the escalating demand for capsule-based nutraceutical formulations is also acting as another significant growth-inducing factor. As per the CRN Consumer Survey, 77% of Americans reported consuming dietary supplements in 2019. Moreover, the survey revealed that vitamins and minerals were the most common supplements consumed by the population across the United States in the same year, accounting for 76% of total dietary supplement consumption. Apart from this, the well-structured healthcare systems in Canada are also encouraging investments in R&D activities, which are anticipated to fuel the empty capsules market in North America over the forecasted period.
The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major empty capsules market companies have also been provided. Some of the key players in the market include: